Wednesday, June 26, 2019

NIH Changing Program Announcement Usage

The National Institutes of Health (NIH) are streamlining methods for announcing specific research interests. They will be phasing out the use of program announcements (PAs), which often come with multiple flavors (e.g., Clinical Trial Allowed/Not Allowed, R01, R03, R21), replacing them with Notices of Special Interest (wait for it, NOSI). ​Requests for Applications (RFAs), program announcements with special receipt/referral/review considerations (PARs) and program announcements with set-aside funds (PASs) will continue to be used. NOSIs will highlight specific research topics of interest, and then typically direct applicants to one or more parent announcements. When applying through a NOSI (I'm loving this acronym), it is critical that the notice number be included in the Agency Routing Identifier field to allow NIH to assign and track these applications appropriately.

This welcome news from the NIH creates a much simpler and intuitive for accessing and applying to the appropriate mechanism at the NIH.

Resources:
NIH Notices of Special Interest

No comments:

Post a Comment

Thanks for your comment; it will be posted shortly. - Naomi